Marxreiter, Franz http://orcid.org/0000-0002-5187-4344
Gaßner, Heiko
Borozdina, Olga
Barth, Jens
Kohl, Zacharias
Schlachetzki, Johannes C. M.
Thun-Hohenstein, Caroline
Volc, Dieter
Eskofier, Bjoern M. http://orcid.org/0000-0002-0417-0336
Winkler, Jürgen
Klucken, Jochen http://orcid.org/0000-0002-5306-920X
Funding for this research was provided by:
Licher MT
IZKF Erlangen
Article History
Received: 13 May 2018
Revised: 8 August 2018
Accepted: 11 August 2018
First Online: 8 September 2018
Compliance with ethical standards
:
: This study was supported by LicherMT GmbH and an intramural grant (Emerging Field Initiative—EFI_Moves) of the Friedrich-Alexander University Erlangen-Nürnberg (FAU). This work has been supported by MoveIT, an EIT Health innovation project. EIT Health is supported by EIT, a body of the European Union. The funding sources had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. Franz Marxreiter is supported by the Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the University of Erlangen-Nuremberg (Clinician Scientist Program; Junior project 51). He received travel grants from IPSEN and Abbvie Inc. Bjoern M Eskofier reports grants outside the submitted work from Adidas AG, Agaplesion gAG, and Bosch Sensortec GmbH. He received compensation from lecturing for AbbVie Deutschland GmbH & Co. KG and Agaplesion gAG. He is a co-founder and co-owner of Portabiles GmbH and Portabiles HealthCare Technologies GmbH, and co-inventor of gait analysis patent application EP 16174268.9. Jochen Klucken received compensation and honoraria from serving on scientific advisory boards for LicherMT GmbH, Abbvie GmbH, UCB Pharma GmbH and GlaxoSmithKline GmbH & Co. KG, Athenion GmbH, Thomashilfen GmbH and from lecturing for UCB Pharma GmbH, TEVA Pharma GmbH, Licher MT GmbH, Desitin GmbH, Abbvie GmbH, Solvay Pharmaceuticals, and Ever Neuro Pharma GmbH. He holds shares from Portabiles GmbH, Portabiles HCT GmbH, and alpha-Telemed AG and is and co-inventor of gait analysis patent application EP 16174268.9. Jürgen Winkler reports personal fees outside of the submitted work from Desitin Arzneimittel GmbH, Abbvie GmbH & Co. KG, and Biogen GmbH. The other authors declare no competing interests.